|Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array|
RA Eeles, AA Al Olama, S Benlloch, EJ Saunders, DA Leongamornlert, ...
Nature genetics 45 (4), 385-391, 2013
|A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer|
AA Al Olama, Z Kote-Jarai, SI Berndt, DV Conti, F Schumacher, Y Han, ...
Nature genetics 46 (10), 1103-1109, 2014
|Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study|
Z Kote-Jarai, AA Al Olama, GG Giles, G Severi, J Schleutker, M Weischer, ...
Nature genetics 43 (8), 785-791, 2011
|Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci|
FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ...
Nature genetics 50 (7), 928-936, 2018
|Active surveillance for clinically localized prostate cancer––A systematic review|
FB Thomsen, K Brasso, LH Klotz, MA Røder, KD Berg, P Iversen
Journal of surgical oncology 109 (8), 830-835, 2014
|A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease|
A Amin Al Olama, Z Kote-Jarai, FR Schumacher, F Wiklund, SI Berndt, ...
Human molecular genetics 22 (2), 408-415, 2013
|ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer|
KD Berg, B Vainer, FB Thomsen, MA Røder, TA Gerds, BG Toft, K Brasso, ...
European urology 66 (5), 851-860, 2014
|Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans|
A Amin Al Olama, T Dadaev, DJ Hazelett, Q Li, D Leongamornlert, ...
Human molecular genetics 24 (19), 5589-5602, 2015
|The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium|
NM Davies, TR Gaunt, SJ Lewis, J Holly, JL Donovan, FC Hamdy, ...
Cancer Causes & Control 26 (11), 1603-1616, 2015
|Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts|
TM Seibert, CC Fan, Y Wang, V Zuber, R Karunamuni, JK Parsons, ...
bmj 360, 2018
|Risk analysis of prostate cancer in PRACTICAL, a multinational consortium, using 25 known prostate cancer susceptibility loci|
AA Al Olama, S Benlloch, AC Antoniou, GG Giles, G Severi, DE Neal, ...
Cancer Epidemiology and Prevention Biomarkers 24 (7), 1121-1129, 2015
|Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate|
FB Thomsen, MA Røder, P Rathenborg, K Brasso, M Borre, P Iversen
Scandinavian journal of urology 48 (3), 268-275, 2014
|Trends in incidence and 5‐year mortality in men with newly diagnosed, metastatic prostate cancer—A population‐based analysis of 2 national cohorts|
JT Helgstrand, MA Røder, N Klemann, BG Toft, DY Lichtensztajn, ...
Cancer 124 (14), 2931-2938, 2018
|Active surveillance can reduce overtreatment in patients with low-risk prostate cancer|
FB Thomsen, MA Røder, H Hvarness, P Iversen, K Brasso
Histopathology 2 (18), 10.8, 2013
|A large-scale analysis of genetic variants within putative miRNA binding sites in prostate cancer|
S Stegeman, E Amankwah, K Klein, TA O'Mara, D Kim, HY Lin, ...
Cancer discovery 5 (4), 368-379, 2015
|Prediction of individual genetic risk to prostate cancer using a polygenic score|
R Szulkin, T Whitington, M Eklund, M Aly, RA Eeles, D Easton, ...
The Prostate 75 (13), 1467-1474, 2015
|Risk of prostate cancer diagnosis and mortality in men with a benign initial transrectal ultrasound-guided biopsy set: a population-based study|
N Klemann, MA Røder, JT Helgstrand, K Brasso, BG Toft, B Vainer, ...
The Lancet Oncology 18 (2), 221-229, 2017
|Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants|
T Dadaev, EJ Saunders, PJ Newcombe, E Anokian, DA Leongamornlert, ...
Nature communications 9 (1), 1-19, 2018
|Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis|
B Malling, MA Røder, K Brasso, J Forman, M Taudorf, L Lönn
European radiology 29 (1), 287-298, 2019
|Does cytoreductive prostatectomy really have an impact on prognosis in prostate cancer patients with low-volume bone metastasis? Results from a prospective case-control study|
T Steuber, KD Berg, MA Røder, K Brasso, P Iversen, H Huland, A Tiebel, ...
European urology focus 3 (6), 646-649, 2017